SECTION I: REPORT OVERVIEW1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape and Market Trends
2.2.2. Market Forecast and Opportunity Analysis
2.2.3. Comparative Analysis
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Types of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach
2.4.2.2. Advantages of Primary Research
2.4.2.3. Techniques for Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions
2.4.2.4. Key Opinion Leaders Considered in Primary Research
2.4.2.4.1. Company Executives (CXOs)
2.4.2.4.2. Board of Directors
2.4.2.4.3. Company Presidents and Vice Presidents
2.4.2.4.4. Research and Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors and Other Healthcare Providers
2.4.2.5. Ethics and Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity
2.4.3. Analytical Tools and Databases
2.5. Robust Quality Control
3. MARKET DYNAMICS
3.1. Chapter Overview
3.2. Forecast Methodology
3.2.1. Top-down Approach
3.2.2. Bottom-up Approach
3.2.3. Hybrid Approach
3.3. Market Assessment Framework
3.3.1. Total Addressable Market (TAM)
3.3.2. Serviceable Addressable Market (SAM)
3.3.3. Serviceable Obtainable Market (SOM)
3.3.4. Currently Acquired Market (CAM)
3.4. Forecasting Tools and Techniques
3.4.1. Qualitative Forecasting
3.4.2. Correlation
3.4.3. Regression
3.4.4. Extrapolation
3.4.5. Convergence
3.4.6. Sensitivity Analysis
3.4.7. Scenario Planning
3.4.8. Data Visualization
3.4.9. Time Series Analysis
3.4.10. Forecast Error Analysis
3.5. Key Considerations
3.5.1. Demographics
3.5.2. Government Regulations
3.5.3. Reimbursement Scenarios
3.5.4. Market Access
3.5.5. Supply Chain
3.5.6. Industry Consolidation
3.5.7. Pandemic / Unforeseen Disruptions Impact
3.6. Limitations
4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Major Currencies Affecting the Market
4.2.2.2. Factors Affecting Currency Fluctuations on the Industry
4.2.2.3. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Currency Exchange Rate
4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
4.2.6. Interest Rates
4.2.6.1. Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.8.3. Trade Policies
4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers
4.2.8.5. Impact of Trade Barriers on the Market
4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War
4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. Stock Market Performance
4.2.11.7. Cross Border Dynamics
4.3. Conclusion
SECTION II: QUALITATIVE INSIGHTS5. EXECUTIVE SUMMARY6. INTRODUCTION
6.1. Chapter Overview
6.2. Introduction to Generative AI
6.3. Evolution of AI
6.4. Applications of Generative AI in Healthcare
6.4.1. Healthcare Research
6.4.1.1. Drug Discovery and Development
6.4.2. Disease Diagnosis and Prognosis
6.4.3. Treatment and Medical Care
6.4.4. Marketing and Administrative Tasks
6.5. Challenges Associated with the Adoption of Generative AI
6.6. Future Perspectives
SECTION III: MARKET OVERVIEW7. COMPETITIVE LANDSCAPE
7.1. Chapter Overview
7.2. Generative AI Companies in Healthcare: Overall Market Landscape
7.2.1. Analysis by Year of Establishment
7.2.2. Analysis by Company Size
7.2.3. Analysis by Location of Headquarters
7.2.4. Analysis by Company Size and Location of Headquarters (Region)
7.2.5. Analysis by Type of Generative AI Company
7.2.6. Analysis by Type of Offering
7.2.7. Analysis by Application Area
7.2.8. Analysis by End-user
8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodology
8.4. Generative AI Companies in Healthcare: Company Competitiveness Analysis
8.4.1. Generative AI Companies based in North America
8.4.2. Generative AI Companies based in Europe and Asia-Pacific
SECTION IV: COMPANY PROFILES9. NORTH AMERICA BASED GENERATIVE AI COMPANIES IN HEALTHCARE
9.1. Chapter Overview
9.2. Detailed Profiles of Generative AI Companies Based in North America
9.2.1. IBM
9.2.1.1. Company Overview
9.2.1.2. Management Team
9.2.1.3. Contact Details
9.2.1.4. Financial Performance
9.2.1.5. Operating Business Segments
9.2.1.6. Generative AI in Healthcare Portfolio
9.2.1.7. Recent Developments and Future Outlook
9.2.2. Microsoft
9.2.3. NVIDIA
9.2.4. OpenAI
9.3. Short Profiles of Generative AI Companies Based in North America
9.3.1. Amazon Web Services
9.3.2. C3 AI
9.3.3. Google
9.3.4. Oracle
9.3.5. Syntegra
10. EUROPE AND ASIA-PACIFIC BASED GENERATIVE AI COMPANIES IN HEALTHCARE
10.1. Chapter Overview
10.2. Detailed Profiles of Generative AI Companies Based in Europe and Asia-Pacific
10.2.1. Huma
10.2.1.1. Company Overview
10.2.1.2. Management Team
10.2.1.3. Contact Details
10.2.1.4. Generative AI in Healthcare Portfolio
10.2.1.5. Recent Developments and Future Outlook
10.2.2. LeewayHertz
10.3. Short Profiles of Generative AI Companies Based in Europe and Asia-Pacific
10.3.1. Exscientia
10.3.2. Iktos
10.3.3. Medical IP
10.3.4. PhamaX
SECTION V: MARKET TRENDS11. PARTNERSHIPS AND COLLABORATIONS
11.1. Chapter Overview
11.2. Partnership Models
11.3. Generative AI in Healthcare Providers: Partnerships and Collaborations
11.3.1. Analysis by Year of Partnership
11.3.2. Analysis by Type of Partnership
11.3.3. Analysis by Year and Type of Partnership
11.3.4. Analysis by Type of Partner Company
11.3.5. Analysis by Purpose of Partnership
11.3.6. Analysis by Geography
11.3.6.1. Local and International Agreements
11.3.6.2. Intracontinental and Intercontinental Agreements
11.3.7. Most Active Players: Analysis by Number of Partnerships
12. GENERATIVE AI IN HEALTHCARE: USE CASES
12.1. Chapter Overview
12.2. Use Case 1: Collaboration between NVIDIA and Genentech
12.2.1. NVIDIA
12.2.2. Genentech
12.2.3. Business Needs
12.2.4. Objectives Achieved and Solutions Provided
12.3. Use Case 2: Collaboration between Insilico Medicine and Inimmune
12.3.1. Insilico Medicine
12.3.2. Inimmune
12.3.3. Business Needs
12.3.4. Objectives Achieved and Solutions Provided
12.4. Use Case 3: Collaboration between OpenAI and Moderna
12.4.1. OpenAI
12.4.2. Moderna
12.4.3. Business Needs
12.4.4. Objectives Achieved and Solutions Provided
12.5. Use Case 4: Collaboration between Amazon Web Services and Pfizer
12.5.1. Amazon Web Services
12.5.2. Pfizer
12.5.3. Business Needs
12.5.4. Objectives Achieved and Solutions Provided
12.6. Use Case 5: Collaboration between Suki and Ascension Saint Thomas
12.6.1. Suki
12.6.2. Ascension Saint Thomas
12.6.3. Business Needs
12.6.4. Objectives Achieved and Solutions Offered
12.7. Use Case 6: Collaboration between Abridge and Emory Healthcare
12.7.1. Abridge
12.7.2. Emory Healthcare
12.7.3. Business Needs
12.7.4. Objectives Achieved and Solutions Offered
12.8. Use Case 7: Collaboration between Google and China Medical University Hospital
12.8.1. Google
12.8.2. China Medical University Hospital
12.8.3. Business Needs
12.8.4. Objectives Achieved and Solutions Provided
SECTION VI: MARKET OPPORTUNITY ANALYSIS13. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
13.1. Chapter Overview
13.2. Market Drivers
13.3. Market Restraints
13.4. Market Opportunities
13.5. Market Challenges
13.6. Conclusion
14. GLOBAL GENERATIVE AI in healthcare MARKET
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Global Generative AI in Healthcare Market, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.4. Multivariate Scenario Analysis
14.4.1. Conservative Scenario
14.4.2. Optimistic Scenario
14.5. Key Market Segmentations
15. GENERATIVE AI IN HEALTHCARE MARKET, BY PURPOSE
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Generative AI in Healthcare Market: Distribution by Purpose
15.3.1. Generative AI in Healthcare Market for Clinical-based Purpose, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
15.3.2. Generative AI in Healthcare Market for System-based Purpose, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
15.4. Data Triangulation and Validation
16. GENERATIVE AI IN HEALTHCARE MARKET, BY TYPE OF OFFERING
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Generative AI in Healthcare Market: Distribution by Type of Offering
16.3.1. Generative AI in Healthcare Market for Technology / Platform, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.3.2. Generative AI in Healthcare Market for Services, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.4. Data Triangulation and Validation
17. GENERATIVE AI IN HEALTHCARE MARKET, BY APPLICATION AREA
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Generative AI in Healthcare Market: Distribution by Application Area
17.3.1. Generative AI in Healthcare Market for Drug Discovery and Development, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.3.2. Generative AI in Healthcare Market for Diagnosis, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.3.3. Generative AI in Healthcare Market for Treatment, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.3.4. Generative AI in Healthcare Market for Administrative Tasks, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.3.5. Generative AI in Healthcare Market for Other Applications, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.4. Data Triangulation and Validation
18. GENERATIVE AI IN HEALTHCARE MARKET, BY END-USER
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Generative AI in Healthcare Market: Distribution by End-user
18.3.1. Generative AI in Healthcare Market for Pharmaceutical and Life Science Companies, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.3.2. Generative AI in Healthcare Market for Healthcare Providers, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.3.3. Generative AI in Healthcare Market for Other End-users, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.4. Data Triangulation and Validation
19. GENERATIVE AI IN HEALTHCARE MARKET, BY GEOGRAPHICAL REGIONS
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Generative AI in Healthcare Market: Distribution by Geographical Regions
19.3.1. Generative AI in Healthcare Market in North America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.1.1. Generative AI in Healthcare Market in the US, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.1.2. Generative AI in Healthcare Market in Canada, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.2. Generative AI in Healthcare Market in Europe, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.2.1. Generative AI in Healthcare Market in Germany, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.2.2. Generative AI in Healthcare Market in the UK, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.2.3. Generative AI in Healthcare Market in France, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.2.4. Generative AI in Healthcare Market in Spain, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.2.5. Generative AI in Healthcare Market in Switzerland, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.2.6. Generative AI in Healthcare Market in the Netherlands, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.2.7. Generative AI in Healthcare Market in Rest of Europe, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.3. Generative AI in Healthcare Market in Asia-Pacific, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.3.1. Generative AI in Healthcare Market in China, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.3.2. Generative AI in Healthcare Market in Japan, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.3.3. Generative AI in Healthcare Market in South Korea, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.3.4. Generative AI in Healthcare Market in Singapore, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.3.5. Generative AI in Healthcare Market in India, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.3.6. Generative AI in Healthcare Market in Rest of Asia-Pacific, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.4. Generative AI in Healthcare Market in Middle East and North Africa, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.4.1. Generative AI in Healthcare Market in Israel, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.4.2. Generative AI in Healthcare Market in UAE, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.4.3. Generative AI in Healthcare Market in Rest of Middle East and North Africa, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.5. Generative AI in Healthcare Market in Latin America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.5.1. Generative AI in Healthcare Market in Brazil, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.3.5.2. Generative AI in Healthcare Market in Rest of Latin America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.4. Generative AI in Healthcare Market, By Geographical Regions: Market Dynamics Assessment
19.4.1. Penetration-Growth (P-G) Matrix
19.4.2. Market Movement Analysis
19.5. Data Triangulation and Validation
20. GENERATIVE AI IN HEALTHCARE MARKET, BY LEADING PLAYERS
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Generative AI in Healthcare Market: Distribution by Leading Generative AI Companies
20.4. Data Triangulation and Validation
21. ADJACENT MARKET ANALYSISSECTION VII: STRATEGIC TOOLS22. PORTER’S FIVE FORCES ANALYSIS
22.1. Chapter Overview
22.2. Significance of Porter’s Five Forces Analysis
22.3. Methodology and Assumptions
22.4. Porter’s Five Forces
22.4.1. Threats of New Entrants
22.4.2. Bargaining Power of Buyers
22.4.3. Bargaining Power of Generative AI Companies
22.4.4. Threats of Substitute Products
22.4.5. Rivalry Among Existing Competitors
22.5. Concluding Remarks
SECTION VIII: OTHER EXCLUSIVE INSIGHTS23. INSIGHTS FROM PRIMARY RESEARCH24. CONCLUDING REMARKSSECTION IX: APPENDIX25. TABULATED DATA26. LIST OF COMPANIES AND ORGANIZATIONS27. CUSTOMIZATION OPPORTUNITIESLIST OF FIGURES
Figure 2.1 Research Methodology: Project Methodology
Figure 2.2 Research Methodology: Data Sources for Secondary Research
Figure 2.3 Research Methodology: Robust Quality Control
Figure 3.1 Market Dynamics: Forecast Methodology
Figure 3.2 Market Dynamics: Market Assessment Framework
Figure 4.1 Lesson Learnt from Past Recessions
Figure 5.1 Executive Summary: Market Landscape
Figure 5.2 Executive Summary: Partnerships and Collaborations
Figure 5.3 Executive Summary: Market Forecast and Opportunity Analysis
Figure 6.1 Workflow of Generative AI
Figure 6.2 Evolution of AI
Figure 6.3 Applications of Generative AI in Healthcare
Figure 6.4 Challenges Associated with the Adoption of Generative AI
Figure 7.1 Generative AI Companies in Healthcare: Distribution by Year of Establishment
Figure 7.2 Generative AI Companies in Healthcare: Distribution by Company Size
Figure 7.3 Generative AI Companies in Healthcare: Distribution by Location of Headquarters
Figure 7.4 Generative AI Companies in Healthcare: Distribution by Company Size and Location of Headquarters (Region)
Figure 7.5 Generative AI Companies in Healthcare: Distribution by Type of Generative AI Company
Figure 7.6 Generative AI Companies in Healthcare: Distribution by Type of Offering
Figure 7.7 Generative AI Companies in Healthcare: Distribution by Application Area
Figure 7.8 Generative AI Companies in Healthcare: Distribution by End-user
Figure 8.1 Company Competitiveness Analysis: Generative AI Companies based in North America
Figure 8.2 Company Competitiveness Analysis: Generative AI Companies based in Europe and Asia-Pacific
Figure 9.1 IBM: Annual Revenues, FY 2021 onwards (USD Million)
Figure 9.2 Microsoft: Annual Revenues, FY 2021 onwards (USD Million)
Figure 9.3 NVIDIA: Annual Revenues, FY 2021 onwards (USD Million)
Figure 11.1 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2019
Figure 11.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 11.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 11.4 Partnerships and Collaborations: Distribution by Type of Partner Company
Figure 11.5 Partnerships and Collaborations: Distribution by Purpose of Partnership
Figure 11.6 Partnerships and Collaborations: Distribution by Local and International Agreements
Figure 11.7 Partnerships and Collaborations: Distribution by Intracontinental and Intercontinental Agreements
Figure 11.8 Most Active Players: Distribution by Number of Partnerships
Figure 13.1 Global Generative AI in Healthcare Market, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 13.2 Global Generative AI in Healthcare Market, Forecasted Estimates (Till 2035): Conservative Scenario (USD Billion)
Figure 13.3 Global Generative AI in Healthcare Market, Forecasted Estimates (Till 2035): Optimistic Scenario (USD Billion)
Figure 15.1 Generative AI in Healthcare Market: Distribution by Type of Purpose
Figure 15.2 Generative AI in Healthcare Market for Clinical-based Purpose, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 15.3 Generative AI in Healthcare Market for System-based Purpose, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 16.1 Generative AI in Healthcare Market: Distribution by Type of Offering
Figure 16.2 Generative AI in Healthcare Market for Technology / Platform, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 16.3 Generative AI in Healthcare Market for Services, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 17.1 Generative AI in Healthcare Market: Distribution by Application Area
Figure 17.2 Generative AI in Healthcare Market for Drug Discovery and Development, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 17.3 Generative AI in Healthcare Market for Diagnosis, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 17.4 Generative AI in Healthcare Market for Treatment, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 17.5 Generative AI in Healthcare Market for Administrative Tasks, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 17.6 Generative AI in Healthcare Market for Other Applications, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 18.1 Generative AI in Healthcare Market: Distribution by End-user
Figure 18.2 Generative AI in Healthcare Market for Pharmaceutical and Life Science Companies, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 18.3 Generative AI in Healthcare Market for Healthcare Providers, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 18.4 Generative AI in Healthcare Market for Other End-users, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.1 Generative AI in Healthcare Market: Distribution by Key Geographical Regions
Figure 19.2 Generative AI in Healthcare Market in North America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.3 Generative AI in Healthcare Market in the US, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.4 Generative AI in Healthcare Market in Canada, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.5 Generative AI in Healthcare Market in Europe, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion) (USD Billion)
Figure 19.6 Generative AI in Healthcare Market in Germany, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.7 Generative AI in Healthcare Market in the UK, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.8 Generative AI in Healthcare Market in France, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.9 Generative AI in Healthcare Market in Spain, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.10 Generative AI in Healthcare Market in Switzerland, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.11 Generative AI in Healthcare Market in the Netherlands, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.12 Generative AI in Healthcare Market in Rest of Europe, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.13 Generative AI in Healthcare Market in Asia-Pacific, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.14 Generative AI in Healthcare Market in China, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.15 Generative AI in Healthcare Market in Japan, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.16 Generative AI in Healthcare Market in South Korea, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.17 Generative AI in Healthcare Market in Singapore, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.18 Generative AI in Healthcare Market in India, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.19 Generative AI in Healthcare Market in Rest of Asia-Pacific, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.20 Generative AI in Healthcare Market in Middle East and North Africa, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.21 Generative AI in Healthcare Market in Israel, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.22 Generative AI in Healthcare Market in UAE, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.23 Generative AI in Healthcare Market in Rest of Middle East and North Africa, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.24 Generative AI in Healthcare Market in Latin America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.25 Generative AI in Healthcare Market in Brazil, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.26 Generative AI in Healthcare Market in Rest of Latin America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Figure 19.27 Penetration-Growth (P-G) Matrix
Figure 19.28 Market Movement Analysis
Figure 20.1 Generative AI in Healthcare Market: Distribution by Leading Generative AI Companies
Figure 22.1 Porter’s Five Forces
Figure 22.2 Threats of New Entrants: Key Factors
Figure 22.3 Bargaining Power of Buyers: Key Factors
Figure 22.4 Bargaining Power of Generative AI Companies: Key Factors
Figure 22.5 Threats of Substitute Products: Key Factors
Figure 22.6 Rivalry Among Existing Competitors: Key Factors
Figure 22.7 Porter’s Five Forces Analysis: Concluding Remarks
Figure 23.1 Concluding Remarks: Market Landscape
Figure 23.2 Concluding Remarks: Partnerships and Collaborations
Figure 23.3 Concluding Remarks: Market Forecast and Opportunity Analysis
LIST OF TABLES
Table 7.1 Generative AI Companies in Healthcare: Information on Year of Establishment, Company Size and Location of Headquarters
Table 7.2 Generative AI Companies in Healthcare: Information on Type of Generative AI Company and Type of Offering
Table 7.3 Generative AI Companies in Healthcare: Information on Application Area
Table 7.4 Generative AI Companies in Healthcare: Information on End-user
Table 9.1 Generative AI Companies based in North America: List of Companies Profiled
Table 9.2 IBM: Company Overview
Table 9.3 IBM: Generative AI in Healthcare Portfolio
Table 9.4 IBM: Recent Developments and Future Outlook
Table 9.5 Microsoft: Company Overview
Table 9.6 Microsoft: Generative AI in Healthcare Portfolio
Table 9.7 Microsoft: Recent Developments and Future Outlook
Table 9.8 NVIDIA: Company Overview
Table 9.9 NVIDIA: Generative AI in Healthcare Portfolio
Table 9.10 NVIDIA: Recent Developments and Future Outlook
Table 9.11 OpenAI: Company Overview
Table 9.12 OpenAI: Generative AI in Healthcare Portfolio
Table 9.13 OpenAI: Recent Developments and Future Outlook
Table 9.14 Amazon Web Services: Company Overview
Table 9.15 Amazon Web Services: Generative AI in Healthcare Portfolio
Table 9.16 C3 AI: Company Overview
Table 9.17 C3 AI: Generative AI in Healthcare Portfolio
Table 9.18 Google: Company Overview
Table 9.19 Google: Generative AI in Healthcare Portfolio
Table 9.20 Oracle: Company Overview
Table 9.21 Oracle: Generative AI in Healthcare Portfolio
Table 9.22 Syntegra: Company Overview
Table 9.23 Syntegra: Generative AI in Healthcare Portfolio
Table 10.1 Generative AI Companies based in Europe and Asia-Pacific: List of Companies Profiled
Table 10.2 Huma: Company Overview
Table 10.3 Huma: Generative AI in Healthcare Portfolio
Table 10.4 Huma: Recent Developments and Future Outlook
Table 10.5 LeewayHertz: Company Overview
Table 10.6 LeewayHertz: Generative AI in Healthcare Portfolio
Table 10.7 LeewayHertz: Recent Developments and Future Outlook
Table 10.8 Exscientia: Company Overview
Table 10.9 Exscientia: Generative AI in Healthcare Portfolio
Table 10.10 Iktos: Company Overview
Table 10.11 Iktos: Generative AI in Healthcare Portfolio
Table 10.12 Medical IP: Company Overview
Table 10.13 Medical IP: Generative AI in Healthcare Portfolio
Table 10.14 PhamaX: Company Overview
Table 10.15 PhamaX: Generative AI in Healthcare Portfolio
Table 11.1 Generative AI Companies in Healthcare: List of Partnerships and Collaborations, Since 2019
Table 11.2 Generative AI Companies in Healthcare: Information on Type of Partner Company and Purpose of Partnership
Table 11.3 Generative AI Companies in Healthcare: Information on Type of Agreement (Country-wise and Region-wise)
Table 23.1 Absci: Company Overview
Table 23.2 aiOla: Company Overview
Table 23.3 Iktos: Company Overview
Table 25.1 Generative AI Companies in Healthcare: Distribution by Year of Establishment
Table 25.2 Generative AI Companies in Healthcare: Distribution by Company Size
Table 25.3 Generative AI Companies in Healthcare: Distribution by Location of Headquarters
Table 25.4 Generative AI Companies in Healthcare: Distribution by Company Size and Location of Headquarters (Region)
Table 25.5 Generative AI Companies in Healthcare: Distribution by Type of Generative AI Company
Table 25.6 Generative AI Companies in Healthcare: Distribution by Type of Offering
Table 25.7 Generative AI Companies in Healthcare: Distribution by Application Area
Table 25.8 Generative AI Companies in Healthcare: Distribution by End-user
Table 25.9 IBM: Annual Revenues, FY 2021 onwards (USD Million)
Table 25.10 Microsoft: Annual Revenues, FY 2021 onwards (USD Million)
Table 25.11 NVIDIA: Annual Revenues, FY 2021 onwards (USD Million)
Table 25.12 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2019
Table 25.13 Partnerships and Collaborations: Distribution by Type of Partnership
Table 25.14 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 25.15 Partnerships and Collaborations: Distribution by Type of Partner Company
Table 25.16 Partnerships and Collaborations: Distribution by Purpose of Partnership
Table 25.17 Partnerships and Collaborations: Distribution by Local and International Agreements
Table 25.18 Partnerships and Collaborations: Distribution by Intracontinental and Intercontinental Agreements
Table 25.19 Most Active Players: Distribution by Number of Partnerships
Table 25.20 Global Generative AI in Healthcare Market, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion)
Table 25.21 Global Generative AI in Healthcare Market, Forecasted Estimates (Till 2035): Conservative Scenario (USD Billion)
Table 25.22 Global Generative AI in Healthcare Market, Forecasted Estimates (Till 2035): Optimistic Scenario (USD Billion)
Table 25.23 Generative AI in Healthcare Market: Distribution by Type of Purpose
Table 25.24 Generative AI in Healthcare Market for Clinical-based Purpose, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.25 Generative AI in Healthcare Market for System-based Purpose, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.26 Generative AI in Healthcare Market: Distribution by Type of Offering
Table 25.27 Generative AI in Healthcare Market for Technology / Platform, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.28 Generative AI in Healthcare Market for Services, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.29 Generative AI in Healthcare Market: Distribution by Application Area
Table 25.30 Generative AI in Healthcare Market for Drug Discovery and Development, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.31 Generative AI in Healthcare Market for Diagnosis, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.32 Generative AI in Healthcare Market for Treatment, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.33 Generative AI in Healthcare Market for Administrative Tasks, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.34 Generative AI in Healthcare Market for Other Applications, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.35 Generative AI in Healthcare Market: Distribution by End-user
Table 25.36 Generative AI in Healthcare Market for Pharmaceutical and Life Science Companies, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.37 Generative AI in Healthcare Market for Healthcare Providers, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.38 Generative AI in Healthcare Market for Other End-users, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.39 Generative AI in Healthcare Market: Distribution by Key Geographical Regions
Table 25.40 Generative AI in Healthcare Market in North America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.41 Generative AI in Healthcare Market in the US, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.42 Generative AI in Healthcare Market in Canada, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.43 Generative AI in Healthcare Market in Europe, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035) (USD Billion), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.44 Generative AI in Healthcare Market in Germany, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.45 Generative AI in Healthcare Market in the UK, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.46 Generative AI in Healthcare Market in France, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.47 Generative AI in Healthcare Market in Spain, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.48 Generative AI in Healthcare Market in Switzerland, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.49 Generative AI in Healthcare Market in the Netherlands, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.50 Generative AI in Healthcare Market in Rest of Europe, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.51 Generative AI in Healthcare Market in Asia-Pacific, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.52 Generative AI in Healthcare Market in China, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.53 Generative AI in Healthcare Market in Japan, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.54 Generative AI in Healthcare Market in South Korea, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.55 Generative AI in Healthcare Market in Singapore, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.56 Generative AI in Healthcare Market in India, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.57 Generative AI in Healthcare Market in Middle East and North Africa, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.58 Generative AI in Healthcare Market in Israel, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.59 Generative AI in Healthcare Market in UAE, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.60 Generative AI in Healthcare Market in Rest of Middle East and North Africa, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.61 Generative AI in Healthcare Market in Latin America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.62 Generative AI in Healthcare Market in Brazil, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.63 Generative AI in Healthcare Market in Rest of Latin America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035), Conservative, Base and Optimistic Scenarios (USD Billion)
Table 25.64 Generative AI in Healthcare Market: Distribution by Leading Generative AI Companies